Soleno Therapeutics Inc. (SLNO)
NASDAQ: SLNO
· Real-Time Price · USD
71.63
-5.73 (-7.41%)
At close: Aug 15, 2025, 3:59 PM
72.00
0.52%
After-hours: Aug 15, 2025, 07:57 PM EDT
Soleno Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -4.71M | -43.77M | -55.98M | -76.62M | -21.85M | -21.4M | -11.3M | -10.86M | -8.47M | -8.36M | -5.49M | -6.13M | -6.72M | -5.72M | -2.83M | -8.14M | -10.99M | -8.95M |
Depreciation & Amortization | 502K | 504K | 503K | 500K | 494K | 490K | 489K | 490K | 489K | 490K | 488K | 492K | 492K | 492K | 492K | 492K | 490K | 489K |
Stock-Based Compensation | 9.7M | 14.68M | 29.75M | 56.6M | 7.16M | 6.45M | 1.91M | 2.2M | 1.2M | 631K | 632K | 683K | 571K | 644K | 418K | 906K | 857K | 1.09M |
Other Working Capital | n/a | -3.02M | 31K | -422K | 254K | -2.93M | 1.87M | 439K | 133K | -887K | 294K | 181K | 158K | 88K | -941K | 306K | -92K | -186K |
Other Non-Cash Items | -18.1M | n/a | -876K | 2.49M | 13.04M | 2.56M | 3.53M | 1.09M | 406K | 393K | -524K | 202K | 686K | -816K | -3.26M | 620K | 3.11M | -911K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2.85M | 653K | -1K | n/a | n/a | n/a | n/a | n/a | -139K | -112K | -56K | -201K |
Change in Working Capital | n/a | -6.36M | 2.61M | 2.1M | -4.04M | 1.94M | 1.91M | 98K | 811K | 114K | -253K | 99K | 356K | -958K | -1.54M | 828K | -1.43M | 994K |
Operating Cash Flow | -12.61M | -32.75M | -23.99M | -14.93M | -17.65M | -12.53M | -6.31M | -6.33M | -5.57M | -6.73M | -5.14M | -4.66M | -4.62M | -6.36M | -6.86M | -5.41M | -8.01M | -7.49M |
Capital Expenditures | -9K | -5K | -8K | -191K | -8K | -11K | n/a | n/a | n/a | n/a | -6K | -7K | -7K | n/a | -13K | -5K | n/a | -4K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -59.41M | -45.36M | -47.55M | -47.77M | -145.91M | -115.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 51.5M | 68.3M | 54M | 52M | 25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -120.91M | -115.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -7.92M | 22.94M | 6.44M | 4.04M | -120.92M | -115.24M | n/a | n/a | n/a | n/a | -6K | -7K | -7K | n/a | -13K | -5K | n/a | -4K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5K | n/a | 2K | -5K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -120K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 15.69M | 3.22M | 57.06M | 2.91M | 152.75M | 938K | 5.63M | 36.53M | n/a | n/a | -15.14M | n/a | n/a | -16K | n/a | n/a | n/a | -120K |
Financial Cash Flow | 15.69M | 3.22M | 57.06M | 2.27M | 152.75M | 938K | 123.56M | 39.4M | 17.06M | n/a | -13.75M | 342K | -282K | 14.03M | -5K | n/a | 2K | -125K |
Net Cash Flow | -4.83M | -6.6M | 39.52M | -8.61M | 14.18M | -126.83M | 117.24M | 33.07M | 11.49M | -6.73M | -5.15M | -4.31M | -4.91M | 7.67M | -6.88M | -5.41M | -8.01M | -7.62M |
Free Cash Flow | -12.62M | -32.76M | -24M | -15.12M | -17.66M | -12.54M | -6.31M | -6.33M | -5.57M | -6.73M | -5.15M | -4.66M | -4.63M | -6.36M | -6.88M | -5.41M | -8.01M | -7.49M |